| Net Cash Provided by (Used in) Operating Activities |
$38,900,000 |
USD |
-34% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$47,500,000 |
USD |
-34% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$112,300,000 |
USD |
-50% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
300,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
60,500,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$51,500,000 |
USD |
58% |
Q1 2024 |
Q1 2024 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$1,800,000 |
USD |
-31% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$947,400,000 |
USD |
95% |
Q4 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$13,800,000 |
USD |
|
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2025 |
FY 2025 |
| Current Income Tax Expense (Benefit) |
$169,300,000 |
USD |
29% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
20,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$400,000 |
USD |
-69% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$250,100,000 |
USD |
-21% |
Q4 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$35,600,000 |
USD |
15% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |